IRIS

PEVIANI, MARCO

PEVIANI, MARCO  

DIPARTIMENTO DI BIOLOGIA E BIOTECNOLOGIE "LAZZARO SPALLANZANI"  

Mostra records
Risultati 1 - 20 di 36 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autore(i) File
(R)-RC-33 as Promising Neuroprotective Agent Acting as Sigma1 Receptor Agonist 1-gen-2014 Rossi, Daniela; Marra, Annamaria; Erik, Laurini; Sabrina, Pricl; Dirk, Schepmann; Bernhard, Wuensch; Peviani, Marco; Curti, Daniela; Collina, Simona
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor- ligand interaction? 1-gen-2015 Rossi, Daniela; Marra, Annamaria; Rui, Marta; Erik, Laurini; Maurizio, Fermeglia; Sabrina, Pricl; Dirk, Schepmann; Bernhard, Wuensch; Peviani, Marco; Curti, Daniela; Collina, Simona
Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. 1-gen-2005 Cheroni, C; Peviani, Marco; Cascio, P; Debiasi, S; Monti, C; Bendotti, C.
Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release 1-gen-2019 Peviani, M.; Capasso Palmiero, U.; Cecere, F.; Milazzo, R.; Moscatelli, D.; Biffi, A.
Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization 1-gen-2021 Rossino, G.; Rui, M.; Linciano, P.; Rossi, D.; Boiocchi, M.; Peviani, M.; Poggio, E.; Curti, D.; Schepmann, D.; Wünsch, B.; González-Avendaño, M.; Vergara-Jaque, A.; Caballero, J.; Collina, S.
Chemical, pharmacological and in vivo pharmacokinetic studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists 1-gen-2015 Marra, Annamaria; Rossi, Daniela; Peviani, Marco; Cavaletti, G; Dondio, G; Curti, Daniela; Collina, Simona
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists. 1-gen-2013 Rossi, Daniela; Pedrali, Alice; Gaggeri, RAFFAELLA FRANCESCA; Marra, Annamaria; Pignataro, L; Laurini, E; Dal Col, V; Fermeglia, M; Pricl, S; Schepmann, D; Wuensch, B; Peviani, Marco; Curti, Daniela; Collina, Simona
COMPOSITIONS AND METHODS FOR TARGETING CELLS 1-gen-2019 Peviani, Marco; Biffi, Alessandra; Moscatelli, Davide; Capasso, Palmiero Umberto; Auriemma, Renato; Sponchioni, Mattia; Politi, Letterio Salvatore
COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM 1-gen-2018 Biffi, Alessandra; Peviani, Marco; Moscatelli, Davide; Capotondo, Alessia; Milazzo, Rita; Capasso Palmiero, Umberto
Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System 1-gen-2021 Meneghini, Vasco; Peviani, Marco; Luciani, Marco; Zambonini, Giada; Gritti, Angela
Development of easy-to-use reverse-phase liquid chromatographic methods for determining PRE-084, RC-33 and RC-34 in biological matrices. The first step for in vivo analysis of sigma1 receptor agonists. 1-gen-2016 Marra, Annamaria; Rossi, Daniela; Maggi, Lauretta; Corana, Federica; Mannucci, Barbara; Peviani, Marco; Curti, Daniela; Collina, Simona
Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis 1-gen-2015 Marino, M.; Papa, S.; Crippa, V.; Nardo, G.; Peviani, M.; Cheroni, C.; Trolese, M. C.; Lauranzano, E.; Bonetto, V.; Poletti, A.; Debiasi, S.; Ferraiuolo, L.; Shaw, P. J.; Bendotti, C.
Fast deep learning reconstruction techniques for preclinical magnetic resonance fingerprinting 1-gen-2024 Cabini, Raffaella Fiamma; Barzaghi, Leonardo; Cicolari, Davide; Arosio, Paolo; Carrazza, Stefano; Figini, Silvia; Filibian, Marta; Gazzano, Andrea; Krause, Rolf; Mariani, Manuel; Peviani, Marco; Pichiecchio, Anna; Pizzagalli, Diego Ulisse; Lascialfari, Alessandro
Heterogeneity of neuroinflammatory responses in amyotrophic lateral sclerosis: A challenge or an opportunity? 1-gen-2020 Cipollina, G.; Serej, A. D.; Nolfi, G. D.; Gazzano, A.; Marsala, A.; Spatafora, M. G.; Peviani, M.
Hydrazone linked doxorubicin-PLA prodrug nanoparticles with high drug loading 1-gen-2018 Gatti, S.; Agostini, A.; Palmiero, U. C.; Colombo, C.; Peviani, M.; Biffi, A.; Moscatelli, D.
Identification of a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. 1-gen-2011 Rossi, Daniela; Pedrali, Alice; Urbano, Mariangela; Gaggeri, RAFFAELLA FRANCESCA; Serra, Massimo; Fernández, L; Fernández, M; Caballero, J; Ronsisvalle, S; Prezzavento, O; Schepmann, D; Wuensch, B; Peviani, Marco; Curti, Daniela; Azzolina, Ornella; Collina, Simona
Identification of RC-33 as a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability. 1-gen-2013 Rossi, Daniela; Marra, Annamaria; P., Picconi; Serra, Massimo; Catenacci, Laura; Sorrenti, MILENA LILLINA; E., Laurini; M., Fermeglia; S., Pricl; S., Brambilla; N., Almirante; Peviani, Marco; Curti, Daniela; Collina, Simona
In Situ Agar – Carbomer Hydrogel Polycondensation:a Chemical Approach to Regenerative Medicine 1-gen-2011 Perale, Giuseppe; Veglianese, Pietro; Rossi, Filippo; Peviani, Marco; Santoro, Marco; Llupi, Dorina; Micotti, Edoardo; Forloni, Gianluigi; Masi, Maurizio
Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase. 1-gen-2005 Bendotti, C; Bao Cutrona, M; Cheroni, C; Grignaschi, G; Lo Coco, D; Peviani, Marco; Tortarolo, M; Veglianese, P; Zennaro, E.
Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells 1-gen-2017 Capotondo, A.; Milazzo, R.; Garcia-Manteiga, J. M.; Cavalca, E.; Montepeloso, A.; Garrison, B. S.; Peviani, M.; Rossi, D. J.; Biffi, A.